8-KThe WireRoutine
Bylaw Amendment
Filed Dec 10, 2020 · 5y ago · Accession 0001564590-20-056746
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Eledon Pharmaceuticals, Inc.
- Ticker
- ELDN
- CIK
- 1404281
- Form type
- 8-K
- Filing date
- Dec 10, 2020
- Report date
- Dec 8, 2020
- Document
- nvus-8k_20201208.htm
- Size
- 35 KB